Detalhe da pesquisa
1.
No excess long-term mortality in stage I-IIA Hodgkin lymphoma patients treated with ABVD and limited field radiotherapy.
Br J Haematol
; 188(5): 685-691, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31612478
2.
Nodular lymphocyte predominant Hodgkin lymphoma in Sweden between 2000 and 2014: an analysis of the Swedish Lymphoma Registry.
Br J Haematol
; 177(3): 449-456, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28233899
3.
No survival benefit associated with routine surveillance imaging for Hodgkin lymphoma in first remission: a Danish-Swedish population-based observational study.
Br J Haematol
; 173(2): 236-44, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26846879
4.
Inhibition of geranylgeranylation mediates sensitivity to CHOP-induced cell death of DLBCL cell lines.
Exp Cell Res
; 317(8): 1179-91, 2011 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21324313
5.
The dual role of CD70 in B-cell lymphomagenesis.
Clin Transl Med
; 12(12): e1118, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36471481
6.
Real-world data on treatment concepts in classical Hodgkin lymphoma in Sweden 2000-2014, focusing on patients aged >60 years.
EJHaem
; 2(3): 400-412, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35844675
7.
Identification of molecular targets associated with transformed diffuse large B cell lymphoma using highly purified tumor cells.
Am J Hematol
; 84(12): 803-8, 2009 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19844990
8.
Genes associated with the tumour microenvironment are differentially expressed in cured versus primary chemotherapy-refractory diffuse large B-cell lymphoma.
Br J Haematol
; 141(4): 423-32, 2008 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-18419622
9.
A subset of CD5- diffuse large B-cell lymphomas expresses nuclear cyclin D1 with aberrations at the CCND1 locus.
Am J Clin Pathol
; 129(4): 630-8, 2008 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-18343791
10.
Protein expression and cellular localization in two prognostic subgroups of diffuse large B-cell lymphoma: higher expression of ZAP70 and PKC-beta II in the non-germinal center group and poor survival in patients deficient in nuclear PTEN.
Leuk Lymphoma
; 48(11): 2221-32, 2007 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-17926183
11.
CD40 expression identifies a prognostically favourable subgroup of diffuse large B-cell lymphoma.
Leuk Lymphoma
; 48(9): 1774-9, 2007 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-17786713
12.
Estrogen receptor ß1 in diffuse large B-cell lymphoma growth and as a prognostic biomarker.
Leuk Lymphoma
; 58(2): 418-427, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27357538
13.
Immunohistochemical expression of CD23 and CD40 may identify prognostically favorable subgroups of diffuse large B-cell lymphoma: a Nordic Lymphoma Group Study.
Clin Cancer Res
; 9(2): 722-8, 2003 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-12576441
14.
BCL2 expression in de novo diffuse large B-cell lymphoma partly reflects normal differences in age distribution.
Br J Haematol
; 146(6): 683-4, 2009 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-19508293
15.
Gene expression profiling indicates that immunohistochemical expression of CD40 is a marker of an inflammatory reaction in the tumor stroma of diffuse large B-cell lymphoma.
Leuk Lymphoma
; 53(9): 1764-8, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22335531
16.
CD40 is a potential marker of favorable prognosis in patients with diffuse large B-cell lymphoma treated with immunochemotherapy.
Leuk Lymphoma
; 51(9): 1643-8, 2010 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-20593977
17.
Tissue microarray is inappropriate for analysis of BCL6 expression in diffuse large B-cell lymphoma.
Eur J Haematol
; 79(2): 146-9, 2007 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-17635238
18.
Evaluation of immunophenotype in diffuse large B-cell lymphoma and its impact on prognosis.
Mod Pathol
; 18(8): 1113-20, 2005 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-15920553